
		Search

2012 ACCF/ AATS/ SCAI/ STS Expert Consensus Document on Transcatheter Aortic Valve Replacement

ACCF/ SCAI/ STS/ AATS/ AHA/ ASNC/ HFSA/ SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update

2012 ACCF/ AHA/ ACR/ SCAI/ SIR/ STS/ SVM/ SVN Key Data Elements and Definitions for Peripheral Atherosclerotic Vascular Disease


	About JACC CME
	Policy on Privacy and Confidentiality
	Disclosures
	Important Information


Still not a subscriber to JACC Imaging or JACC Interventions? Click here to sign up now!


	Submit Manuscripts
	Author Information
	Subscribe/Renew
	Order Reprints
	Email Alerts
	Feedback
	RSS Feed
	CME


	Cardiosmart
	Cardiosource
	CVN
	Imaging Library
	JACC Imaging
	JACC Interventions


	About the Journal
	Editorial Board & Staff

	Help viewing high resolution images
	Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.

Figure 5 Plasma TBARS levels in patients with coronary spastic angina before and after treatment in the placebo group and the vitamin E group. *Significant effect of vitamin E treatment compared with values in the placebo group, p < .001 by ANOVA. ${ominus}$ , diltiazem + placebo; •, diltiazem + vitamin E.

Return to article